1 Followers SHG:603392 - Beijing Wantai Biological Pharmacy Enterprise Co Ltd

Beijing Wantai Biological Phar
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	88.59% -0.7%	83.46% -5.8%	83.12% -0.4%
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	35.15% 22.2%	42.34% 20.4%	22.64% -46.5%
Gross Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	85.78% 5.6%	89.54% 4.4%	85.63% -4.4%
Operating Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	42.37% 20.8%	50.06% 18.2%	29.43% -41.2%
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	5.75B 144.3%	11.19B 94.5%	5.51B -50.7%
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	7.05B 99.5%	16.23B 130.3%	15.71B -3.2%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.48B 161.3%	3.66B 47.6%	2.83B -22.7%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	4.47B 74.9%	12.34B 176.3%	12.7B 2.9%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.68B 259.2%	4.13B 145.7%	1.54B -62.8%
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	701.46M 344.3%	1.41B 101.5%	5.19B 266.9%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.41B 101.5%	5.19B 266.9%	3.78B -27.0%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	634.16M 715.4%	3.2B 405.0%	378.15M -88.2%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.08B 205.0%	4.86B 133.9%	1.25B -74.4%
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.643 190.0%	3.79 130.7%	0.99 -73.9%
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	57.59% 74.9%	56.35% -2.2%	9.96% -82.3%
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	38.22% 60.8%	40.69% 6.5%	7.81% -80.8%